Decipher tissue-based molecular test helps personalize high-risk prostate cancer treatment
Prostate cancer is the most common cancer in men – in 2013, it affected more than one million men across the world.
Read original article on The Medical News →Related news
-
Study finds patients experienced rapid weight gain after starting antipsychotic medication
United Kingdom
-
AI gets more diagnoses right than generalist doctors in medical challenge
United Kingdom
-
Using AI in the global fight against HIV
United Kingdom
-
Children who eat more ultraprocessed foods show stronger brain responses to appetizing foods
United Kingdom
-
AI breast cancer survival model could improve accuracy and personalize care
United Kingdom
-
Study identifies potential new ways to treat the most common type of bowel cancer
United Kingdom
-
Tackling diabetes with an electronic implant: How a tiny catalyst lowers blood sugar
United Kingdom
-
Blood biomarker test improves detection of hidden brain injuries
United Kingdom